Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients

Transplant Infectious Disease

Volumn 12, Issue 6, 2010, Pages 505-512

  Mikulska, M ^a   Del Bono, V ^a   Prinapori, R ^a   Boni, L ^b   Raiola, A M ^a   Gualandi, F ^a   Van Lint, M T ^a   Dominietto, A ^a   Lamparelli, T ^a   Cappellano, P ^c   Bacigalupo, A ^a   Viscoli, C ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Allogeneic transplant; Bacteremia; Cephalosporins; Colonization; Enterococcus; HSCT; Mucositis; Sepsis; Vancomycin

Indexed keywords

CEPHALOSPORIN; CIPROFLOXACIN; GLYCOPEPTIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DISEASE SEVERITY; ENTEROCOCCAL INFECTION; FEMALE; GRAFT RECIPIENT; HLA MATCHING; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIPLE MYELOMA; MYELOFIBROSIS; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; THROAT CULTURE;

ADOLESCENT; ADULT; AGED; BACTEREMIA; CASE-CONTROL STUDIES; CEPHALOSPORINS; ENTEROCOCCUS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MUCOSITIS; PHARYNX; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS; VANCOMYCIN; YOUNG ADULT;

EID: 78650077045     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2010.00544.x     Document Type: Article

References (29)

1. Almyroudis NG, Fuller A, Jakubowski A, et al. Pre- and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients. Transpl Infect Dis 2005; 7 (1): 11-17.
2. Collin BA, Leather HL, Wingard JR, Ramphal R. Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clin Infect Dis 2001; 33 (7): 947-953.
3. Ninin E, Milpied N, Moreau P, et al. Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants. Clin Infect Dis 2001; 33 (1): 41-47.
4. Poutsiaka DD, Price LL, Ucuzian A, Chan GW, Miller KB, Snydman DR. Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality. Bone Marrow Transplant 2007; 40 (1): 63-70.
5. Donnelly JP, De Pauw BE. Infections in the immunocompromised host: general principles. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. Philadelphia, PA, USA: Churchill Livingstone, 2005: 3421-3432.
6. Viscoli C, Castagnola E. Treatment of febrile neutropenia: what is new? Curr Opin Infect Dis 2002; 15 (4): 377-382.
7. Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993; 6 (4): 428-442.
8. Jones RN, Marshall SA, Pfaller MA, et al. Nosocomial enterococcal blood stream infections in the SCOPE Program: antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy. SCOPE Hospital Study Group. Diagn Microbiol Infect Dis 1997; 29 (2): 95-102.
9. Pfaller MA, Jones RN, Doern GV, Kugler K. Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob Agents Chemother 1998; 42 (7): 1762-1770.
10. Cappellano P, Viscoli C, Bruzzi P, Van Lint MT, Pereira CA, Bacigalupo A. Epidemiology and risk factors for bloodstream infections after allogeneic hematopoietic stem cell transplantation. New Microbiol 2007; 30 (2): 89-99.
11. Ortega M, Rovira M, Almela M, et al. Bacterial and fungal bloodstream isolates from 796 hematopoietic stem cell transplant recipients between 1991 and 2000. Ann Hematol 2005; 84 (1): 40-46.
12. Mikulska M, Del Bono V, Raiola AM, et al. Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of gram-negative rods and increasing antibiotic resistance. Biol Blood Marrow Transplant 2009; 15 (1): 47-53.
13. Caballero-Granado FJ, Becerril B, Cisneros JM, Cuberos L, Moreno I, Pachon J. Case-control study of risk factors for the development of enterococcal bacteremia. Eur J Clin Microbiol Infect Dis 2001; 20 (2): 83-90.
14. Noskin GA, Peterson LR, Warren JR. Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome. Clin Infect Dis 1995; 20 (2): 296-301.
15. Pallares R, Pujol M, Peña C, Ariza J, Martin R, Gudiol F. Cephalosporins as risk factor for nosocomial Enterococcus faecalis bacteremia. A matched case-control study. Arch Intern Med 1993; 153 (13): 1581-1586.
16. World Health Organization. WHO Handbook for Reporting Results of Cancer Treatment. Geneva, Switzerland: World Health Organization, 1997.
17. Moellering RC Jr. Enterococcus species, Streptococcus bovis, and Leuconostoc species. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. Philadelphia, PA, USA: Churchill Livingstone, 2005: 2411-2421.
18. Feld R. The role of surveillance cultures in patients likely to develop chemotherapy-induced mucositis. Support Care Cancer 1997; 5 (5): 371-375.
19. Czirók E, Prinz GY, Dénes R, Reményi P, Herendi A. Value of surveillance cultures in a bone marrow transplantation unit. J Med Microbiol 1997; 46 (9): 785-791.
20. Weinstock DM, Conlon M, Iovino C, et al. Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transplant 2007; 13 (5): 615-621.
21. Blijlevens NM. Implications of treatment-induced mucosal barrier injury. Curr Opin Oncol 2005; 17 (6): 605-610.
22. Avery R, Kalaycio M, Pohlman B, et al. Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course. Bone Marrow Transplant 2005; 35 (5): 497-499.
23. Dubberke ER, Hollands JM, Georgantopoulos P, et al. Vancomycin-resistant enterococcal bloodstream infections on a hematopoietic stem cell transplant unit: are the sick getting sicker? Bone Marrow Transplant 2006; 38 (12): 813-819.
24. Mikulska M, Raiola AM, Bruno B, et al. Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients. Bone Marrow Transplant 2009; 44 (6): 361-370.
25. Cometta A, Marchetti O, Calandra T. Empirical use of anti-Gram-positive antibiotics in febrile neutropaenic cancer patients with acute leukaemia. Eur J Cancer Supplements 2007; 5 (2): 23-31.
26. Vardakas KZ, Samonis G, Chrysanthopoulou SA, Bliziotis IA, Falagas ME. Role of glycopeptides as part of initial empirical treatment of febrile neutropenic patients: a meta-analysis of randomised controlled trials. Lancet Infect Dis 2005; 5 (7): 431-439.
27. Zaas AK, Song X, Tucker P, Perl TM. Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin resistant enterococci. Clin Infect Dis 2002; 35 (10): 1139-1146.
28. Shaikh ZH, Osting CA, Hanna HA, Arbuckle RB, Tarr JJ, Raad II. Effectiveness of a multifaceted infection control policy in reducing vancomycin usage and vancomycin-resistant enterococci at a tertiary care cancer centre. J Hosp Infect 2002; 51 (1): 52-58.
29. DiazGranados CA, Zimmer SM, Klein M, Jernigan JA. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis 2005; 41 (3): 327-333.